Non-invasive imaging of glycoprotein VI binding to injured arterial lesions

Summary

Glycoprotein VI (GPVI) is the major platelet collagen receptor and plays a critical role in the process of thrombosis at sites of atherosclerotic lesions. This study evaluates the feasibility of radiolabeled soluble GPVI to identify injured arterial lesions. Radiolabeling was carried out using the iodogen method and resulted in the radioiodinated GPVI in radiochemical yields between 97–100%. The biodistribution of [¹²⁵I]GPVI was determined in normal mice and demonstrated a blood clearance halftime of approximately 5.5 hours. Vascular lesions were induced in the carotid artery in wild type and ApoE ^-/- mice. Immediately after injury radioiodinated GPVI was injected intravenously. Binding of [¹²³I]GPVI to carotid lesions was assessed by szinti-graphic in vivo imaging. Carotid arteries were explanted for ex vivo autoradiography and histological characterization of the lesion. In vivo and ex vivo imaging revealed substantial accumulation of radioiodinated GPVI in the injured artery wall, with a ratio of lesion to control vessel of 3:1 and 7:1, respectively. Because GPVI is the critical collagen receptor that mediates platelet adhesion to vascular lesions, soluble radiolabeled GPVI may be an agent for non-invasive imaging of thrombogenic thus, vulnerable atherosclerotic plaques.

Keywords

Glycoprotein VI - platelet - atherosclerosis - autoradiography - molecular imaging

• References

• 1 Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
• 2 Clemetson KJ, Clemetson JM. Platelet collagen receptors. Thromb Haemost 2001; 86: 189-97.
• 3 Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor?. Blood 2003; 102: 449-61.
• 4 Massberg S, Gawaz M, Gruner S. et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003; 197: 41-9.
• 5 Massberg S, Konrad I, Bultmann A. et al. Soluble glycoprotein VI dimer inhibits platelet adhesion and aggregation to the injured vessel wall in vivo. Faseb J 2004; 18: 397-9.
• 6 Moers A, Nieswandt B, Massberg S. et al. G13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 2003; 9: 1418-22.
• 7 Naghavi M, Libby P, Falk E. et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation 2003; 108: 1772-8.
• 8 Ginsberg HN, Goldsmith SJ, Vallabhajosula S. Noninvasive imaging of 99mtechnetium-labeled low density lipoprotein uptake by tendon xanthomas in hypercholesterolemic patients. Arteriosclerosis 1990; 10: 256-62.
• 9 Mettinger KL, Larsson S. Gamma scanning of atherosclerotic plaques in carotid arteries. Lancet 1978; 1: 1267.
• 10 Ohtsuki K, Hayase M, Akashi K. et al. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic stud. Circulation 2001; 104: 203-8.
• 11 Davis HH, Heaton WA, Siegel BA. et al. Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet 1978; 1: 1185-7.
• 12 Davis , 2nd HH, Siegel BA, Sherman LA. et al. Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation 1980; 61: 982-8.
• 13 Schafers M, Riemann B, Kopka K. et al. Scintigraphic imaging ofmatrix metalloproteinase activity in the arterialwall in vivo. Circulation 2004; 109: 2554-9.
• 14 Miura Y, Takahashi T, Jung SM. et al. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI)with collagen. A dimeric formof GPVI, but not the monomeric form, shows affinity to fibrous collagen. J Biol Chem 2002; 277: 46197-204.
• 15 Jandrot-Perrus M, Busfield S, Lagrue AH. et al. Related Articles, Links Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 2000; 96: 1798-807.